When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

As AI begins to transform education, work, and social life, we need to focus on developing and expanding capacities essential ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsBrett Monia - Founder, ...

Biohaven Ltd. (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...

Olema Pharmaceuticals, Inc. ( OLMA) Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 1:00 PM EST ...

Merck , known as MSD outside of the United States and Canada, today announced the presentation of results from three pivotal Phase 3 trials evaluating the investigational, once-daily, oral, two-drug ...

A recent study has revealed how the psychedelic brew ayahuasca alters brain waves to induce profound mystical experiences and ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a fundamentally new mechanism of action in more than half a century. Built on ...

Christina Perrier is InStyle’s assistant editor and a writer in the fashion, celebrity, and lifestyle spaces. Everything, and I mean everything, can always use a little bit of bling, including your ...

Add Yahoo as a preferred source to see more of our stories on Google. Scammers are targeting older people with AI voice cloning scams. (Debalina Ghosh via Getty Images) Criminals are using artificial ...

Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...

Thank you, Jason. After that, we'll provide updates on the significant progress we've made with lonvo-z, which is being developed as a potential one-time treatment for patients with hereditary ...